Stemsation International, Inc. Logo

Stemsation International, Inc.

STSN

(0.0)
Stock Price

0,02 USD

-1099.56% ROA

68.91% ROE

-13.53x PER

Market Cap.

2.203.525,00 USD

-46.07% DER

0% Yield

0% NPM

Stemsation International, Inc. Stock Analysis

Stemsation International, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Stemsation International, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Negative ROE (-8782.8%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

2 ROA

The stock's ROA (-41.01%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

3 PBV

The stock's high Price-to-Book Value (P/BV) ratio (8.73x) suggests it's overvalued, potentially making it an expensive investment.

4 DER

The company has a high debt to equity ratio (1567%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Stemsation International, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Stemsation International, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Stemsation International, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Stemsation International, Inc. Revenue
Year Revenue Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 3.375 100%
2011 2.976 -13.41%
2016 0 0%
2017 0 0%
2018 0 0%
2019 3.236 100%
2020 217.075 98.51%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Stemsation International, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Stemsation International, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 270.840 100%
2016 0 0%
2017 3 100%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Stemsation International, Inc. EBITDA
Year EBITDA Growth
2006 -26.638
2007 -433.381 93.85%
2008 -194.695 -122.59%
2009 -60.107 -223.91%
2010 -133.387 54.94%
2011 -267.864 50.2%
2016 -820 -32566.34%
2017 -2.530 67.59%
2018 -300 -743.33%
2019 -855.070 99.96%
2020 -807.900 -5.84%
2021 -172.660 -367.91%
2022 -57.440 -200.59%
2023 -81.610 29.62%
2024 -1.808.800 95.49%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Stemsation International, Inc. Gross Profit
Year Gross Profit Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 3.375 100%
2011 2.976 -13.41%
2016 0 0%
2017 0 0%
2018 0 0%
2019 2.978 100%
2020 100.596 97.04%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Stemsation International, Inc. Net Profit
Year Net Profit Growth
2006 -26.638
2007 -447.356 94.05%
2008 -267.056 -67.51%
2009 -60.107 -344.3%
2010 -133.762 55.06%
2011 -267.864 50.06%
2016 -26.720 -902.49%
2017 -30.042 11.06%
2018 -29.582 -1.55%
2019 -836.294 96.46%
2020 -1.045.796 20.03%
2021 -1.154.069 9.38%
2022 -438.478 -163.2%
2023 -87.272 -402.43%
2024 -1.809.924 95.18%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Stemsation International, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Stemsation International, Inc. Free Cashflow
Year Free Cashflow Growth
2006 -16.588
2007 -234.694 92.93%
2008 -120.629 -94.56%
2009 -27.511 -338.48%
2010 -150.233 81.69%
2011 571 26410.51%
2017 -2.411 123.68%
2018 -181 -1232.04%
2019 -376.501 99.95%
2020 -685.439 45.07%
2021 -765.703 10.48%
2022 -69.091 -1008.25%
2023 -47.854 -44.38%
2024 -56.772 15.71%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Stemsation International, Inc. Operating Cashflow
Year Operating Cashflow Growth
2006 -6.588
2007 -232.175 97.16%
2008 -120.629 -92.47%
2009 -27.511 -338.48%
2010 -150.233 81.69%
2011 571 26410.51%
2017 -2.411 123.68%
2018 -181 -1232.04%
2019 -376.501 99.95%
2020 -685.439 45.07%
2021 -765.703 10.48%
2022 -69.091 -1008.25%
2023 -47.854 -44.38%
2024 -56.772 15.71%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Stemsation International, Inc. Capital Expenditure
Year Capital Expenditure Growth
2006 10.000
2007 2.519 -296.98%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Stemsation International, Inc. Equity
Year Equity Growth
2006 34.250
2007 -156.550 121.88%
2008 -5.064 -2991.43%
2009 -16.096 68.54%
2010 19.142 184.09%
2011 -285.353 106.71%
2017 -687.575 58.5%
2018 -717.157 4.12%
2019 -44.530 -1510.5%
2020 -230.151 80.65%
2021 -898.069 74.37%
2022 -852.954 -5.29%
2023 -682.227 -25.02%
2024 -753.263 9.43%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Stemsation International, Inc. Assets
Year Assets Growth
2006 144.032
2007 7.752 -1758%
2008 0 0%
2009 0 0%
2010 326.142 100%
2011 243.098 -34.16%
2017 2.259 -10661.31%
2018 1.920 -17.66%
2019 136.884 98.6%
2020 80.436 -70.18%
2021 79.254 -1.49%
2022 59.235 -33.8%
2023 43.001 -37.75%
2024 43.926 2.11%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Stemsation International, Inc. Liabilities
Year Liabilities Growth
2006 109.782
2007 164.302 33.18%
2008 5.064 -3144.51%
2009 16.096 68.54%
2010 307.000 94.76%
2011 528.451 41.91%
2017 689.834 23.39%
2018 719.077 4.07%
2019 181.414 -296.37%
2020 310.587 41.59%
2021 977.323 68.22%
2022 912.189 -7.14%
2023 725.228 -25.78%
2024 797.188 9.03%

Stemsation International, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-13.53x
Price To Sales Ratio
0x
POCF Ratio
-95.23
PFCF Ratio
-32.11
Price to Book Ratio
-8.68
EV to Sales
0
EV Over EBITDA
-5.23
EV to Operating CashFlow
-37.14
EV to FreeCashFlow
-37.14
Earnings Yield
-0.07
FreeCashFlow Yield
-0.03
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.01
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.14
ROE
0.69
Return On Assets
-11
Return On Capital Employed
0.65
Net Income per EBT
1
EBT Per Ebit
0.99
Ebit per Revenue
0
Effective Tax Rate
0.1

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
1.08
Return on Tangible Assets
-11
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
-0.46
Debt to Assets
7.9
Net Debt to EBITDA
-0.71
Current Ratio
0.06
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-753262
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.16

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Stemsation International, Inc. Dividends
Year Dividends Growth

Stemsation International, Inc. Profile

About Stemsation International, Inc.

StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. It offers StemRCM, a dietary supplement that supports stem cells ability to repair, renew, and restore tissues and organ function through healthy stem cell release, circulation, and migration. The company sells its products through independent wellness advocates directly to consumers. StemSation International, Inc. is headquartered in Boca Raton, Florida.

CEO
Mr. Ray C. Carter Jr.
Employee
4
Address
7777 Glades Road
Boca Raton, 33434

Stemsation International, Inc. Executives & BODs

Stemsation International, Inc. Executives & BODs
# Name Age
1 Mr. Nicholas B. Panza
Secretary
70
2 Mr. Ray C. Carter Jr.
Founder, Chief Executive Officer & President
70
3 Dr. Mira Gadzala Ph.D.
Chief Science Officer
70
4 Ms. Svetlana Nedkovska
Managing Director of Europe
70

Stemsation International, Inc. Competitors